These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 36341943)

  • 1. Reliability of common mouse behavioural tests of anxiety: A systematic review and meta-analysis on the effects of anxiolytics.
    Rosso M; Wirz R; Loretan AV; Sutter NA; Pereira da Cunha CT; Jaric I; Würbel H; Voelkl B
    Neurosci Biobehav Rev; 2022 Dec; 143():104928. PubMed ID: 36341943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anxiolytic-like effects of alverine citrate in experimental mouse models of anxiety.
    Gupta D; Radhakrishnan M; Kurhe Y
    Eur J Pharmacol; 2014 Nov; 742():94-101. PubMed ID: 25199966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The benzodiazepine diazepam demonstrates the usefulness of Syrian hamsters as a model for anxiety testing: evaluation of other classes of anxiolytics in comparison to diazepam.
    Gannon RL; Lungwitz E; Batista N; Hester I; Huntley C; Peacock A; Delagrange P; Millan MJ
    Behav Brain Res; 2011 Mar; 218(1):8-14. PubMed ID: 21094664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in anxiety-related behaviours and in sensitivity to diazepam in inbred and outbred strains of mice.
    Griebel G; Belzung C; Perrault G; Sanger DJ
    Psychopharmacology (Berl); 2000 Feb; 148(2):164-70. PubMed ID: 10663431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prior test experience compromises the anxiolytic efficacy of chlordiazepoxide in the mouse light/dark exploration test.
    Holmes A; Iles JP; Mayell SJ; Rodgers RJ
    Behav Brain Res; 2001 Aug; 122(2):159-67. PubMed ID: 11334646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Animal models of anxiety and the development of novel anxiolytic drugs.
    Sanger DJ; Perrault G; Morel E; Joly D; Zivkovic B
    Prog Neuropsychopharmacol Biol Psychiatry; 1991; 15(2):205-12. PubMed ID: 1678541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The anxiolytic activity of calcium-channel blockers in tests of anxious behavior in mice and rats].
    Kozlovskiĭ VL
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1999; 49(1):84-95. PubMed ID: 10330709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential role of AMPA receptors in mouse tests of antidepressant and anxiolytic action.
    Andreasen JT; Fitzpatrick CM; Larsen M; Skovgaard L; Nielsen SD; Clausen RP; Troelsen K; Pickering DS
    Brain Res; 2015 Mar; 1601():117-26. PubMed ID: 25578259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [New anxiolytic drugs: methodological issues].
    Ginestet D; Corruble E
    Encephale; 1993; 19(6):627-37. PubMed ID: 12404782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. nNOS-CAPON blockers produce anxiolytic effects by promoting synaptogenesis in chronic stress-induced animal models of anxiety.
    Zhu LJ; Shi HJ; Chang L; Zhang CC; Si M; Li N; Zhu DY
    Br J Pharmacol; 2020 Aug; 177(16):3674-3690. PubMed ID: 32343840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A way forward for anxiolytic drug development: Testing candidate anxiolytics with anxiety-potentiated startle in healthy humans.
    Grillon C; Ernst M
    Neurosci Biobehav Rev; 2020 Dec; 119():348-354. PubMed ID: 33038346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Anxiety and the mechanisms of action of anxiolytics].
    Marino A; Costa R
    Recenti Prog Med; 1993 Feb; 84(2):129-41. PubMed ID: 8096650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of a modified mirrored chamber sensitive to anxiolytics and anxiogenics in mice.
    Kliethermes CL; Finn DA; Crabbe JC
    Psychopharmacology (Berl); 2003 Sep; 169(2):190-7. PubMed ID: 12783153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Classical and novel approaches to the preclinical testing of anxiolytics: A critical evaluation.
    Haller J; Aliczki M; Gyimesine Pelczer K
    Neurosci Biobehav Rev; 2013 Dec; 37(10 Pt 1):2318-30. PubMed ID: 22981935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prototypical anxiolytics do not reduce anxiety-like behavior in the open field in C57BL/6J mice.
    Thompson T; Grabowski-Boase L; Tarantino LM
    Pharmacol Biochem Behav; 2015 Jun; 133():7-17. PubMed ID: 25812472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the behavioral profile of the non-peptide CRF receptor antagonist CP-154,526 in anxiety models in rodents. Comparison with diazepam and buspirone.
    Griebel G; Perrault G; Sanger DJ
    Psychopharmacology (Berl); 1998 Jul; 138(1):55-66. PubMed ID: 9694527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the predictive validity of the mirror chamber and elevated plus maze tests in mice.
    Paterson NE; Iwunze M; Davis SF; Malekiani SA; Hanania T
    J Neurosci Methods; 2010 Apr; 188(1):62-70. PubMed ID: 20149823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anxiety- and activity-related effects of diazepam and chlordiazepoxide in the rat light/dark and dark/light tests.
    Chaouloff F; Durand M; Mormède P
    Behav Brain Res; 1997 Apr; 85(1):27-35. PubMed ID: 9095339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do animal models of anxiety predict anxiolytic-like effects of antidepressants?
    Borsini F; Podhorna J; Marazziti D
    Psychopharmacology (Berl); 2002 Sep; 163(2):121-41. PubMed ID: 12202959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuromotor tolerability and behavioural characterisation of cannabidiolic acid, a phytocannabinoid with therapeutic potential for anticipatory nausea.
    Brierley DI; Samuels J; Duncan M; Whalley BJ; Williams CM
    Psychopharmacology (Berl); 2016 Jan; 233(2):243-54. PubMed ID: 26439367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.